… This study provides an update to current understanding of the burden of MS on … Belgium,
based on a cross-sectional survey conducted in 2015. Within this effort, participation in Belgium …

… This cross-sectional, observational study was endorsed by the European Multiple Sclerosis
Platform (EMSP) and carried out in collaboration with national MS societies and local clinical …

… The Netherlands and Belgium are the only countries applying the friction cost method, 15
and for reasons of consistency in this current European study, production losses are calculated …

… Hospitalisation in Germany was high compared to most other Western European countries
in our study (comparable to Austria and Belgium). During the preceding 3 months, 532 …

… to update the information on the burden of MS, and this study is part of a European-wide
effort in 16 countries, endorsed by the European Platform of MS Societies (European Multiple …

… Therefore, it is important to update the information on the burden of MS, and this study is
part of a European-wide effort in 16 countries, endorsed by the European Platform of MS …

… in multiple sclerosis (MS) – where lifetime costs and outcomes cannot be observed – outcome
data have to be combined with costs. … Therefore, we report results by EDSS or by disease …

… Also, it will be important to include patients’ perceptions about their HRQoL. Utility provides
important information from the patients’ perspective, and as in previous studies, our results …

… reimbursement decisions of new outpatient drugs … , cost-effectiveness studies and even cost
of illness studies are thus relatively scarce. In multiple sclerosis (MS), however, large burden …

… of patients with relapsing-remitting multiple sclerosis (RRMS) disease and thus … burden of
MS, and this study is part of a European-wide effort in 16 countries, endorsed by the European …